Do you want to skip to content? Skip to content
Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
False /oidc-signin/en-gb/ Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))

Parkinson's disease & Infusion therapy

Get an overview of how neria™ contributes to treatment of Parkinson's disease.
a man and a woman standing in a kitchen ;

What is Parkinson’s disease?

Parkinson’s disease is a degenerative disorder of the central nervous system resulting in the deterioration of the patient’s motor skills, speech and other functions. Some patients may not be able to control their disease effectively with prescribed medication resulting in unpredictable "on/off" fluctuations.

Treatment of Parkinson’s disease with apomorphine

Apomorphine hydrochloride is used to treat Parkinson’s disease. It is often prescribed to patients who are not responding well to other treatments or who experience frequent “off” periods and less control.

Apomorphine is administered subcutaneously:

  • By intermittent injections with a ready-loaded disposable pen
  • As a continuous infusion using a syringe driver infusion pump with a pre-filled syringe

Infusion therapy with apomorphine

Continuous infusion therapy with apomorphine can help improve quality of life for some patients. The patient uses a battery-driven, syringe driver infusion pump to deliver a specified continuous amount of the drug when required, adjusting the amount as needed during the day.

To deliver apomorphine, the patient inserts an infusion set under the skin and connects it to the infusion pump. The patient needs to change the infusion set at least once a day.

Apomorphine and neria™ infusion sets

neria™ infusion sets are tested (in vitro) for use with apomorphine.1 The quality and careful design of neria™ infusion sets make them an excellent choice for the Parkinson's patient treated with continuous apomorphine.

Clinical studies

Clinical studies showed that neria™ infusion sets helped minimize pain2,3 during insertion and reduced needle related traumas.4,5

 

For complete clinical studies, please contact ConvaTec Infusion Care at info.infusion-set@unomedical.com.

For further information on Parkinson's disease, please see parkinson.org.

More in Infusion Therapy

Go to page

Infusion Therapy

a child smiling in water

Primary Immune Deficiency

Learn how neria™ infusion sets are used in Primary Immune Defiency treatments.

Read more

Infusion Therapy

a woman with her hair blowing in the wind

Thalassaemia

Treatments of Thalassaemia with Desferal™ and neria™ infusion sets.

Read more

Infusion Therapy

a woman sitting in a chair talking to a man in a chair

Pain management.

Learn how neria™ infusion sets are recommended for Pain Management.

Read more

Infusion Therapy

placeholder image

Parkinson's Disease.

Get an overview of how neria™ contributes to treatment of Parkinson's disease.

Read more
Go to page

1. Stability test and function test of Comfort and Contact Detach by means of the medicament APO-go. Analysis report no. 294690. January 14-April 1, 2009. Data on file. Unomedical.
2. Chan G.C.F., NgD.M.W. Et al, comparison of Subcutaneous Infusion needles for Transfusion-Dependant Thalasseamia Patients by the Intrapersonal Cross-Over Assessment Model, Am.J. Hematol, 76;398-404
3. Parsons J., Infusion Line prefernces of patients prescribed apomorphine for complex Parkinson’s disease. British Journal of Neuroscience Nursing. December 2009, Vol 5 No 12
4. Chan G.C.F, Ng D.M.W. et al, Comparison of Subcutaneous Infusion Needles for Transfusion-Dependent Thalassemia Patients by the Intrapersonal Cross-Over Assessment Model, Am.J.Hematol.76;398-404 (2004).
5. Parsons J. Infusion line preferences of patients prescribed apomorphine for complex Parkinson's disease. British Journal of Neuroscience Nursing. December 2009.Vol 5 No 12

Visit our neria.com

Explore the universe of neria™ infusion sets

Click here

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?